1Muirhead N. Management of idiopathic membranous nephropathy:evidence-based t~commendations. Kidney Int, 1999,55 (S70) :47.
2Geddes CC, Cattran DC. The treatment of idiopathic membranous nephropathy. Semin Nephrol,2000,20(3) :299.
3Tortes A, Dominguez GB, Carreno A, et al. Conservative versus immunosuppressive treatment of patients with idiopathic membranousnephropathy. Kidney Int,2002,61 (1) :219.
4Miller G,Zimmerman R,Radhakrishnan J,et al. Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kid Dis,2000,14:224.
5Choi MJ, Eustace JA, Gimenez LF, et al. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int,2002,61 (3):1098.
6Branten AJW,Wetzels JFM. Short and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Ciin Nephrol,2001,56(1) :1.
7Ducloux D, Bresson VC, Chalopin J. Use of pentoxifylline in membranous nephropathy. Lancet,2001,357 (9269):1672.
